Featured Conference

Forum on Early Stage Commercialization Strategies for the Pharmaceutical Industry
April 21 – 22, 2005 • Philadelphia, PA

Visit the conference website for more information and to register.

The top performing pharmaceutical companies are differentiated by the quality of their commercial organizations. There are many examples where well-executed commercial strategies have enabled marketed products to beat equally good or better competitor products regardless of the quality of the R&D. To optimize the Research, Development, Clinical (RD&C) and Commercialization functions, it is important to develop supportive processes and multidisciplinary teams. These teams should be aligned with the strategy and business plans for each product and therapeutic area. With each team’s product plan, value determinants can be developed to make decisions, allocate resources and prioritize actions. Every activity should be aligned with a business purpose and a good return for the effort.

CBI’s Forum on Early Commercialization Strategies, will bring together leading industry experts and advanced practitioners to examine the steps companies have taken to map out their early stage commercialization processes, add internal commercialization structure and ensure that new products with merit are not overlooked or under-resourced. In addition, the program will highlight best practices in pipeline and portfolio management to drive portfolio execution and revenue generation.

Forum on Early Commercialization Strategies, April 21 – 22, 2005, Philadelphia, PA, discusses these issues and more!

  • Map out an early stage commercialization strategy to improve information flow across the entire company

  • Optimize efficiencies across the entire new product development team to create real value and dramatically improving profits

  • Understand why lifecycle management and OTC switches are providing the “portfolios” of the future

  • Develop valuable market research analysis to forecast the commercial value of a drug

  • Identify levels of unmet need to determine the commercial viability of a new product in a new market

  • Learn to apply various analytic methodologies to compensate for and understand the impact of uncertainties on the investment decision process

  • Understand how to conduct due diligence in product construct/platform that has no current market proxy

  • Strategies to successfully license and integrate external innovation into a company’s portfolio

  • Integrate market dynamics, product promotion, brand attributes, price and persistency/compliance into your commercialization analysis

For more information or to register, please visit the conference website or contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.

Return to list of conferences…